The benefits of cancer screening in kidney transplant recipients: a single‐center experience

The frequency of malignancy is increasing in kidney transplant recipients. Posttransplant malignancy (PTM) is a major cause of long‐term graft survival inhibition. In this study, we evaluated the frequency and prognosis of PTM at our center and examined the efficacy of cancer screening. Between 1972...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Taigo, Kakuta, Yoichi, Abe, Toyofumi, Yamanaka, Kazuaki, Imamura, Ryoichi, Okumi, Masayoshi, Ichimaru, Naotsugu, Takahara, Shiro, Nonomura, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735786/
https://www.ncbi.nlm.nih.gov/pubmed/26686199
http://dx.doi.org/10.1002/cam4.568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735786/
https://www.ncbi.nlm.nih.gov/pubmed/26686199
http://dx.doi.org/10.1002/cam4.568

Ejemplares similares